Axsome Therapeutics acquires epilepsy drug candidate from AstraZeneca
Go back to Axsome Therapeutics acquires epilepsy drug candidate from AstraZeneca| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 73 | |||||
| (NASDAQ: AXSM) | Delayed: 253.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $253.77 | 52 Week High | $15.74 | |||
| Open | $253.77 | 52 Week Low | $5.37 | |||
| Day High | $253.77 | P/E | N/A | |||
| Day Low | $253.77 | EPS | $0.00 | |||
| Volume | 11 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 4,295 | |||||

